Full Text View
Tabular View
No Study Results Posted
Related Studies
Effect of Oral Contraceptives After Administration of Semaglutide in Subjects With Type 2 Diabetes
This study has been completed.
Study NCT01324505   Information provided by Novo Nordisk

First Received on March 25, 2011.   Last Updated on November 6, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes
Diabetes Mellitus, Type 2
Additional conditions recognized in this trial
Diabetes Mellitus
More general conditions related to this trial
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
semaglutide
placebo
Microgyn®
Additional drug interventions recognized in this trial
Contraceptive Agents
Contraceptives, Oral
Ethinyl Estradiol
Levonorgestrel
More general drug interventions related to this trial
Contraceptive Agents, Female
Contraceptives, Oral, Synthetic
Estrogens
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
Novo Nordisk


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services